Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07134660) titled 'Thoracic Surgery Intercostal Block Trial With Liposomal vs. Hydrochloride Bupivacaine' on Aug. 3.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).
Primary Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Condition:
Postoperative Pain, Acute
Lung Cancer
Intervention:
Procedure: Liposomal Bupivacaine intercostal nerve block
Procedure: Bupivacaine Hydrochloride intercostal nerve block
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: September 1, 202...